OSSIFYING FIBROMYXOID TUMOR, MALIGNANT

Clinical trials for OSSIFYING FIBROMYXOID TUMOR, MALIGNANT explained in plain language.

Never miss a new study

Get alerted when new OSSIFYING FIBROMYXOID TUMOR, MALIGNANT trials appear

Sign up with your email to follow new studies for OSSIFYING FIBROMYXOID TUMOR, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return

Disease control Recruiting now

This study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the drugs pazopanib and selinexor to standard chemotherapy can improve outcomes. Participants receive treatment tailored to their…

Matched conditions: OSSIFYING FIBROMYXOID TUMOR, MALIGNANT

Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

OSSIFYING FIBROMYXOID TUMOR, MALIGNANT

Get alerted when new OSSIFYING FIBROMYXOID TUMOR, MALIGNANT trials appear

New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return